UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 93 filers reported holding UROGEN PHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,296,089 | +12.0% | 125,226 | 0.0% | 0.01% | +66.7% |
| Q1 2023 | $1,157,088 | +4.2% | 125,226 | 0.0% | 0.00% | -57.1% |
| Q4 2022 | $1,110,755 | +6.6% | 125,226 | 0.0% | 0.01% | -46.2% |
| Q3 2022 | $1,042,000 | +1.6% | 125,226 | 0.0% | 0.01% | +18.2% |
| Q2 2022 | $1,026,000 | -8.1% | 125,226 | -2.4% | 0.01% | -35.3% |
| Q1 2022 | $1,117,000 | -8.4% | 128,255 | 0.0% | 0.02% | -10.5% |
| Q4 2021 | $1,220,000 | +621.9% | 128,255 | +1177.3% | 0.02% | +375.0% |
| Q3 2021 | $169,000 | +10.5% | 10,041 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $153,000 | -21.9% | 10,041 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $196,000 | – | 10,041 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |